VARMAM THERAPY WITH AND WITHOUT AMUKKARA CHOORANAM FOR SWASA KAASAM ( BRONCHIAL ASTHMA )

THE THERAPEUTIC EFFICACY OF VARMAM THERAPY WITH AND WITHOUT AMUKKARA CHOORANAM IN THE MANAGEMENT OF SWASA KAASAM (BRONCHIAL ASTHMA)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035602

Enrollment

Registered

2021-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

Intervention1: VARMAM THERAPY AND AMUKKARA CHOORANAM: VARMAM THERAPY AND AMUKKARA CHOORANAM FREQUENCY 5 DAYS ONCE DURATION 90 DAYS DOSAGE 1500 mg bd with milk Control Intervention1: VARMAM THERAPY:

Eligibility

Inclusion criteria

Inclusion criteria: • Patients having the symptoms of Shortness of breath, tightness of chest, wheeze added with rhonchi sound, cough with or without expectoration. • History of allergy. • Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa. • Patient who are willing to undergo laboratory investigation and pulmonary function test (PFT)

Exclusion criteria

Exclusion criteria: • Cardiac asthma • Renal asthma • Tuberculosis • COPD • Status asthmaticus • Patients with uncontrolled diabetes mellitus • Patients with uncontrolled hypertension • Pregnancy and lactation • Psychological diseases

Design outcomes

Primary

Measure	Time frame
The outcome is assessed by Asthma Control Questionnaire. Timepoint: 90 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K VISHNU PRIYA

NATIONAL INSTITUTE OF SIDDHA

sami2011nis@gmail.com7358481734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026